Cargando…
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977416/ https://www.ncbi.nlm.nih.gov/pubmed/24772414 http://dx.doi.org/10.1155/2014/180549 |
_version_ | 1782310414120386560 |
---|---|
author | Lohcharoenkal, Warangkana Wang, Liying Chen, Yi Charlie Rojanasakul, Yon |
author_facet | Lohcharoenkal, Warangkana Wang, Liying Chen, Yi Charlie Rojanasakul, Yon |
author_sort | Lohcharoenkal, Warangkana |
collection | PubMed |
description | Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy. |
format | Online Article Text |
id | pubmed-3977416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39774162014-04-27 Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy Lohcharoenkal, Warangkana Wang, Liying Chen, Yi Charlie Rojanasakul, Yon Biomed Res Int Review Article Nanoparticles have increasingly been used for a variety of applications, most notably for the delivery of therapeutic and diagnostic agents. A large number of nanoparticle drug delivery systems have been developed for cancer treatment and various materials have been explored as drug delivery agents to improve the therapeutic efficacy and safety of anticancer drugs. Natural biomolecules such as proteins are an attractive alternative to synthetic polymers which are commonly used in drug formulations because of their safety. In general, protein nanoparticles offer a number of advantages including biocompatibility and biodegradability. They can be prepared under mild conditions without the use of toxic chemicals or organic solvents. Moreover, due to their defined primary structure, protein-based nanoparticles offer various possibilities for surface modifications including covalent attachment of drugs and targeting ligands. In this paper, we review the most significant advancements in protein nanoparticle technology and their use in drug delivery arena. We then examine the various sources of protein materials that have been used successfully for the construction of protein nanoparticles as well as their methods of preparation. Finally, we discuss the applications of protein nanoparticles in cancer therapy. Hindawi Publishing Corporation 2014 2014-03-20 /pmc/articles/PMC3977416/ /pubmed/24772414 http://dx.doi.org/10.1155/2014/180549 Text en Copyright © 2014 Warangkana Lohcharoenkal et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Lohcharoenkal, Warangkana Wang, Liying Chen, Yi Charlie Rojanasakul, Yon Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title | Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title_full | Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title_fullStr | Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title_full_unstemmed | Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title_short | Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy |
title_sort | protein nanoparticles as drug delivery carriers for cancer therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977416/ https://www.ncbi.nlm.nih.gov/pubmed/24772414 http://dx.doi.org/10.1155/2014/180549 |
work_keys_str_mv | AT lohcharoenkalwarangkana proteinnanoparticlesasdrugdeliverycarriersforcancertherapy AT wangliying proteinnanoparticlesasdrugdeliverycarriersforcancertherapy AT chenyicharlie proteinnanoparticlesasdrugdeliverycarriersforcancertherapy AT rojanasakulyon proteinnanoparticlesasdrugdeliverycarriersforcancertherapy |